AJMC December 9, 2024
Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.
At a recent Institute for Value-Based Medicine® event in Houston focusing on increasing value in cancer care, Bhuvana Sagar, MD, practicing oncologist, Oncology Consultants, shared her insights on the evolving role of precision medicine in oncology. In this interview, Sagar highlights the transformative potential of liquid biopsies and the challenges faced by providers and payers in getting these tests done.
Transcript
How do you see liquid biopsy technology reshaping precision medicine testing in community oncology practices?
I think liquid biopsies are great. I think previously, we only had the tissue testing. So, with tissue testing, a...
Today's Sponsors
Today's Sponsor